NO980296D0 - Forbedrede terapeutiske midler - Google Patents

Forbedrede terapeutiske midler

Info

Publication number: NO980296D0
Authority: NO; Norway
Prior art keywords: therapeutic agents; improved therapeutic; eicosenoyl; improved; elaidoyl
Prior art date: 1995-07-25

Application number

NO980296A

Other languages

English (en)

Other versions

NO980296L (no

NO313985B1 (no

Inventor

Finn Myhren

Bernt Boerretzen

Are Dalen

Kjell Torgeir Stokke

Original Assignee

Norsk Hydro As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-25

Filing date

1998-01-23

Publication date

1998-01-23

1998-01-23 Application filed by Norsk Hydro As filed Critical Norsk Hydro As

1998-01-23 Priority to NO19980296A priority Critical patent/NO313985B1/no

1998-01-23 Publication of NO980296L publication Critical patent/NO980296L/no

1998-01-23 Publication of NO980296D0 publication Critical patent/NO980296D0/no

2003-01-13 Publication of NO313985B1 publication Critical patent/NO313985B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polyamides (AREA)
Artificial Filaments (AREA)

NO19980296A 1995-07-25 1998-01-23 Anvendelse av Ara-C-derivater til fremstilling av farmasöytiske preparatertil behandling av solide tumorer og lymfomer, samt nye Ara-C-derivater og farmasöytiske blandinger som omfatter disse NO313985B1 (no)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO19980296A NO313985B1 (no)	1995-07-25	1998-01-23	Anvendelse av Ara-C-derivater til fremstilling av farmasöytiske preparatertil behandling av solide tumorer og lymfomer, samt nye Ara-C-derivater og farmasöytiske blandinger som omfatter disse

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9515279.9A GB9515279D0 (en)	1995-07-25	1995-07-25	Improved therapeutic agents
PCT/NO1996/000179 WO1997005154A1 (en)	1995-07-25	1996-07-12	Improved therapeutic agents
NO19980296A NO313985B1 (no)	1995-07-25	1998-01-23	Anvendelse av Ara-C-derivater til fremstilling av farmasöytiske preparatertil behandling av solide tumorer og lymfomer, samt nye Ara-C-derivater og farmasöytiske blandinger som omfatter disse

Publications (3)

Publication Number	Publication Date
NO980296L NO980296L (no)	1998-01-23
NO980296D0 true NO980296D0 (no)	1998-01-23
NO313985B1 NO313985B1 (no)	2003-01-13

Family

ID=10778247

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19980296A NO313985B1 (no)	1995-07-25	1998-01-23	Anvendelse av Ara-C-derivater til fremstilling av farmasöytiske preparatertil behandling av solide tumorer og lymfomer, samt nye Ara-C-derivater og farmasöytiske blandinger som omfatter disse

Country Status (25)

Country	Link
US (2)	US6316425B1 (no)
EP (1)	EP0842185B1 (no)
JP (2)	JP4372227B2 (no)
KR (1)	KR100401909B1 (no)
AT (1)	ATE207076T1 (no)
AU (1)	AU714814B2 (no)
CA (1)	CA2227533C (no)
CZ (1)	CZ291612B6 (no)
DE (1)	DE69616074T2 (no)
DK (1)	DK0842185T3 (no)
ES (1)	ES2166900T3 (no)
GB (1)	GB9515279D0 (no)
HU (1)	HU224839B1 (no)
IL (2)	IL122942A0 (no)
MX (1)	MX9800622A (no)
NO (1)	NO313985B1 (no)
NZ (1)	NZ313790A (no)
PL (1)	PL183601B1 (no)
PT (1)	PT842185E (no)
RU (1)	RU2165260C2 (no)
SK (1)	SK283003B6 (no)
TW (1)	TW434251B (no)
UA (1)	UA55389C2 (no)
WO (1)	WO1997005154A1 (no)
ZA (1)	ZA966047B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6458772B1 (en)	1909-10-07	2002-10-01	Medivir Ab	Prodrugs
WO1998021223A1 (en) *	1996-11-12	1998-05-22	Medivir Ab	Nucleosides
UA67736C2 (uk) *	1997-01-24	2004-07-15	Конфарма Ас	Похідні гемцитабіну, спосіб їх одержання та фармацевтична композиція на їх основі
US7393862B2 (en) *	2002-05-17	2008-07-01	Celgene Corporation	Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
JP2007509994A (ja) *	2003-11-03	2007-04-19	コグニス・アイピー・マネージメント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	アシルリボヌクレオシドおよびアシルデオキシリボヌクレオシド
NO324263B1 (no) *	2005-12-08	2007-09-17	Clavis Pharma Asa	Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
US8497292B2 (en) *	2005-12-28	2013-07-30	Translational Therapeutics, Inc.	Translational dysfunction based therapeutics
WO2009042767A1 (en) *	2007-09-26	2009-04-02	Mount Sinai School Of Medicine	Azacytidine analogues and uses thereof
GB0808357D0 (en) *	2008-05-08	2008-06-18	Cyclacel Ltd	Process
AU2010322516A1 (en) *	2009-11-20	2012-05-17	Clavis Pharma Asa	Parenteral formulations of gemcitabine derivatives
CA2805171A1 (en) *	2010-07-13	2012-01-19	Clavis Pharma Asa	Parenteral formulations of elacytarabine derivatives
CA2865742C (en) *	2012-03-28	2017-04-18	Fujifilm Corporation	Salt of 1-(2-deoxy-2-fluoro-4-thio-.beta.-d-arabinofuranosyl)cytosine
US12059427B2 (en)	2018-01-15	2024-08-13	Yinuoke Medicine Science And Technology Company Ltd.	Treatments for cachexia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3894000A (en) *	1971-01-27	1975-07-08	Upjohn Co	Ara-cytidine derivatives and process of preparation
RU2085557C1 (ru)	1991-09-30	1997-07-27	Санкио Компани Лимитед	Производные нуклеозидов пиримидина или их фармацевтически приемлемые соли и способ их получения
GB9307043D0 (en) *	1993-04-05	1993-05-26	Norsk Hydro As	Chemical compounds
US5641758A (en)	1993-11-10	1997-06-24	Kluge; Michael	Cytarabine derivatives, the preparation and use thereof

1995
- 1995-07-25 GB GBGB9515279.9A patent/GB9515279D0/en active Pending
1996
- 1996-07-12 SK SK80-98A patent/SK283003B6/sk not_active IP Right Cessation
- 1996-07-12 PT PT96926032T patent/PT842185E/pt unknown
- 1996-07-12 DE DE69616074T patent/DE69616074T2/de not_active Expired - Lifetime
- 1996-07-12 NZ NZ313790A patent/NZ313790A/xx not_active IP Right Cessation
- 1996-07-12 KR KR10-1998-0700463A patent/KR100401909B1/ko not_active IP Right Cessation
- 1996-07-12 JP JP50750497A patent/JP4372227B2/ja not_active Expired - Fee Related
- 1996-07-12 ES ES96926032T patent/ES2166900T3/es not_active Expired - Lifetime
- 1996-07-12 CZ CZ1998163A patent/CZ291612B6/cs not_active IP Right Cessation
- 1996-07-12 AU AU66335/96A patent/AU714814B2/en not_active Ceased
- 1996-07-12 HU HU9900924A patent/HU224839B1/hu not_active IP Right Cessation
- 1996-07-12 PL PL96324690A patent/PL183601B1/pl not_active IP Right Cessation
- 1996-07-12 AT AT96926032T patent/ATE207076T1/de active
- 1996-07-12 DK DK96926032T patent/DK0842185T3/da active
- 1996-07-12 WO PCT/NO1996/000179 patent/WO1997005154A1/en active IP Right Grant
- 1996-07-12 IL IL12294296A patent/IL122942A0/xx active IP Right Grant
- 1996-07-12 US US08/983,483 patent/US6316425B1/en not_active Expired - Lifetime
- 1996-07-12 EP EP96926032A patent/EP0842185B1/en not_active Expired - Lifetime
- 1996-07-12 CA CA002227533A patent/CA2227533C/en not_active Expired - Fee Related
- 1996-07-12 RU RU98103238/04A patent/RU2165260C2/ru not_active IP Right Cessation
- 1996-07-16 ZA ZA9606047A patent/ZA966047B/xx unknown
- 1996-10-02 TW TW085111996A patent/TW434251B/zh not_active IP Right Cessation
- 1996-12-07 UA UA98020922A patent/UA55389C2/uk unknown
1998
- 1998-01-15 IL IL122942A patent/IL122942A/en not_active IP Right Cessation
- 1998-01-21 MX MX9800622A patent/MX9800622A/es not_active IP Right Cessation
- 1998-01-23 NO NO19980296A patent/NO313985B1/no not_active IP Right Cessation
1999
- 1999-11-09 US US09/435,641 patent/US6335322B1/en not_active Expired - Fee Related
2009
- 2009-07-03 JP JP2009159081A patent/JP5087052B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IL122942A (en)	2006-12-10
CA2227533C (en)	2007-01-09
CZ16398A3 (cs)	1998-06-17
JP5087052B2 (ja)	2012-11-28
HUP9900924A2 (hu)	2001-05-28
PL324690A1 (en)	1998-06-08
DK0842185T3 (da)	2002-02-04
US6335322B1 (en)	2002-01-01
EP0842185A1 (en)	1998-05-20
SK8098A3 (en)	1998-07-08
KR100401909B1 (ko)	2004-02-14
WO1997005154A1 (en)	1997-02-13
JP2002504068A (ja)	2002-02-05
JP4372227B2 (ja)	2009-11-25
EP0842185B1 (en)	2001-10-17
IL122942A0 (en)	1999-05-09
SK283003B6 (sk)	2003-01-09
AU714814B2 (en)	2000-01-13
DE69616074D1 (de)	2001-11-22
HU224839B1 (en)	2006-03-28
US6316425B1 (en)	2001-11-13
NO980296L (no)	1998-01-23
RU2165260C2 (ru)	2001-04-20
PT842185E (pt)	2002-04-29
HUP9900924A3 (en)	2001-06-28
NZ313790A (en)	1999-07-29
UA55389C2 (uk)	2003-04-15
TW434251B (en)	2001-05-16
ZA966047B (en)	1997-02-04
KR19990035804A (ko)	1999-05-25
GB9515279D0 (en)	1995-09-20
ES2166900T3 (es)	2002-05-01
CZ291612B6 (cs)	2003-04-16
PL183601B1 (pl)	2002-06-28
JP2009215326A (ja)	2009-09-24
AU6633596A (en)	1997-02-26
ATE207076T1 (de)	2001-11-15
CA2227533A1 (en)	1997-02-13
MX9800622A (es)	1998-11-30
NO313985B1 (no)	2003-01-13
DE69616074T2 (de)	2002-06-06

Publication	Publication Date	Title
IS4706A (is)	1998-03-31	Lyfjasamsetningar
TR199901174T2 (xx)	1999-08-23	Yeni heterosiklilmetil-ikameli pirazol t�revleri.
DZ2494A1 (fr)	2003-01-25	Composition pharmaceutique d'oméprazole.
DE19681287T1 (de)	1998-03-19	Orale Formulierung von 2-Methylthienobenzodiazepin
ITRM960810A0 (it)	1996-11-27	Composizioni farmaceutiche contenenti ciclosporine o macrolidi
DE69631056D1 (de)	2004-01-22	Zusammensetzungen von süssigkeiten
ID18663A (id)	1998-04-30	Komposisi farmasi berlapis enterik
CY1108610T1 (el)	2014-04-09	Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
CY2005007I2 (el)	2009-11-04	Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
NO20021172D0 (no)	2002-03-08	Farmasöytisk sammensetning
DE59709414D1 (de)	2003-04-03	Oxyiminopregnancarbolactone
PT907364E (pt)	2002-12-31	Composicao farmaceutica de libertacao sustida
BR9711586A (pt)	1999-08-24	Compostos e uso dos mesmo
NO980296D0 (no)	1998-01-23	Forbedrede terapeutiske midler
EP0932606A4 (en)	2000-01-19	Inhibitors of prenyl transferases
FI965204L (fi)	1997-02-21	Bromelaiinin lääkekäyttö
ATE203519T1 (de)	2001-08-15	Chinolinderivate als antimalariamittel
FI973229L (fi)	1997-08-05	Uusi farmaseuttinen koostumus
LV11727A (lv)	1997-04-20	Farmaceitiska kompozicija
ATE228575T1 (de)	2002-12-15	Wirkstoffkombinationen
FI973280A0 (fi)	1997-08-08	Farmaseuttinen koostumus
FI963263L (fi)	1996-08-21	Bromelaiinin lääkinnällinen käyttö
DE69631339D1 (de)	2004-02-19	Verwaltung kryptographischer schlüssel
DE69611546D1 (de)	2001-02-15	Herstellung von 2,6-dimethylnaphthalin
BR9608978A (pt)	1999-06-29	Inibidor de protease de serina derivado de imidazo [1,5a] piridina composição farmacêutica e utilização do inibidor de protease

Legal Events

Date	Code	Title	Description
2014-02-24	MM1K	Lapsed by not paying the annual fees